Content Navigation
( All
None )
Target General Information |
Top |
Target ID |
T40474 |
Target Info
|
Target Name |
Proto-oncogene c-Met (MET) |
Synonyms |
Tyrosine-protein kinase Met; Scatter factor receptor; SF receptor; Met proto-oncogene tyrosine kinase; Hepatocyte growth factor receptor; HGF/SF receptor; HGF-SF receptor; HGF receptor; C-met; C-Met receptor tyrosine kinase |
Target Type |
Successful Target |
Gene Name |
MET |
Biochemical Class |
Kinase |
UniProt ID |
|
Targeted Antigens of CAR-T Cell Therapy |
Top |
CAR T-Cell Therapy Drug(s) |
Anti-C-met CAR-T cells |
Drug Info
|
Phase 1/2 |
Renal cell carcinoma |
[1] |
Autologous T Cells Expressing MET scFv CAR |
Drug Info
|
Phase 1 |
Melanoma |
[2] |
Autologous T Cells Expressing MET scFv CAR |
Drug Info
|
Phase 0 |
Breast cancer |
[2] |
References |
Top |
REF 1 |
ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
|
REF 2 |
ClinicalTrials.gov (NCT03060356) Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.